Advanced Enzyme Technologies Ltd.
ADVENZYMES Share PricePharmaceuticals & Drugs
₹314
0.4 (0.1%)
As on December 4, 2025
Exchange Scrips: BSE540025NSEADVENZYMESISININE837H01020
Market Cap ₹ 3,504 Cr
P/E Ratio 26.79
Dividend Yield 0.83 %
Performance
Market performance
Open313.15
High315.05
Volumes60,163
Prev314
Low310.35
As on2025-12-04
Historical performance
1 Year High411.4
3 Year High571
5 Year High571
1 Year Low257.9
3 Year Low225
5 Year Low225
Fundamentals
Company Valuation
Market Cap (₹Cr)
3,504
Face Value (₹)
2
P/E Ratio
26.79
Dividend Yield
0.83 %
Investment Returns
1 Year
-16%
3 Years
10.7%
5 Years
-10.3%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 312.28 | Bullish |
| 10-DMA | 312.99 | Bullish |
| 20-DMA | 319.18 | Bearish |
| 50-DMA | 316.83 | Bearish |
| 100-DMA | 322.97 | Bearish |
| 200-DMA | 310.51 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 14 | 14 | 14 | 11 | 11 |
| Foreign Investors | 5 | 5 | 5 | 5 | 5 |
| Domestic Investors | 9 | 9 | 9 | 6 | 6 |
| Public Investors | 69623 | 67575 | 65308 | 67340 | 66747 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 26.79.
- 3Y Stock Price CAGR of the stock is 0.7.
- The stock has a beta of 0.9.
- In the last financial year, the company had an EBITDA of ₹2286 Million.
- The company generated revenue of ₹6369 Million in the previous financial year.
Advanced Enzyme Technologies Ltd.
3140.4 (0.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 835884.5
No. of Shares: 2662 (Approx)
Performance:-16.4%
P/L: ₹-164115.5
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
